Results 301 to 310 of about 8,093,285 (389)

Patient-reported outcome measures in emergency and acute care: looking beyond the emergency room [PDF]

Clinical and Experimental Emergency Medicine
Jason B. Liu, David W. Bates
doaj   +1 more source

Patient-Reported Outcomes Among an Observational Cohort of Individuals With Chronic Low Back Pain. [PDF]

JOR Spine
Greco CM, Dodds NE, Acevedo AM, Anderst W, Bell KM, Darwin J, Delitto A, Jakicic JM, McKernan GP, Patterson CG, Pilkonis PA, Piva SR, Schneider MJ, Vo NV, Wasan AD, Yu L, Sowa GA.   +16 more
europepmc   +1 more source

QL4 THE CONTENT VALIDITY OF CLINICIAN DERIVED PATIENT REPORTED OUTCOMES (PRO) MEASURES: THE ROLAND MORRIS DISABILITY QUESTIONNAIRE

, 2005
N. Horowicz-Mehler, Catherine Evans, Linda Abetz, C West, Catherine Copley‐Merriman   +4 more
openalex   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain Management. [PDF]

Health Serv Insights
Bollinger A, Hersberger KE, Gianora J, Urdieux IO, Meyer Zu Schwabedissen HE, Rommers N, Schwenkglenks M, Stäuble CK, Allemann SS.   +8 more
europepmc   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Contemporary Long-Term Patient Reported Outcomes of Pilon Fractures. [PDF]

ANZ J Surg
Ryan TJ, Enninghorst N, Partridge J, Sulemain A, Du Plessis J, Henry C, Weaver N, Tarrant SM, Balogh ZJ.   +8 more
europepmc   +1 more source

PCV19 A LITERATURE REVIEW OF PATIENT-REPORTED OUTCOMES (PRO) USED IN ATRIAL FIBRILLATION

, 2005
V Staniek, MC Minjoulat-Rey, S Gabriel, MP Emery, Benoît Arnould, Łukasz Prost, O Bouin   +6 more
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Patient-Reported Outcomes in Integrated Care: A Frontier of Opportunities and Challenges. [PDF]

Int J Integr Care
Anderson N, Hughes SE, Aiyegbusi OL, Collis P, Miller R, Calvert M.   +5 more
europepmc   +1 more source